1. ACME Solar Holdings:

This renewable energy company rose 8.2% in the past week after winning a 25-year contract from government-owned renewable energy company SECI. The company will supply 300 MW of power during a four-hour peak-demand window at Rs 6 per unit.

ACME already has a lead in battery storage. By July, it had 3.6 GWh of operational capacity, roughly 40% of India’s commissioned battery capacity. It is targeting more than 10 GWh by the end of FY27, nearly nine months earlier than planned.

The company is using batteries meant for future long-term projects to make short-term power sales. It has locked in more than Rs 1,400 crore of FY27 revenue from these contracts, which typically fetch Rs 8-10 per unit. 

Battery sales already contributed nearly a quarter of Q1FY27 revenue. CEO Nikhil Dhingra said, “You can expect this opportunity to sustain beyond FY27 for the next couple of years.”

ACME’s renewable plants also produced 23% more power YoY in Q1, helped by better sunlight and new capacity. About three-fourths of its 5.1 GW under construction is already covered by long-term power contracts.

The company has the land and grid connections needed for these projects, while funding is in place for nearly 85% of the signed capacity. ACME also raised Rs 2,800 crore from institutional investors to reduce debt and strengthen its balance sheet. Forecaster expects FY27 revenue to nearly double and net profit to rise 75%.

ICICI Securities reiterated its ‘Buy’ rating with a higher target price of Rs 450. It expects battery storage and new long-term power contracts to drive earnings. The brokerage flagged delays in signing the remaining contracts or completing projects as the key risks.

2. Godrej Agrovet:

This agri-business company rose 6.4% on Tuesday after Kotak Securities raised its target price to Rs 1,010, implying a 57% upside, and kept its ‘Buy’ rating. The brokerage calls the company’s oil palm business a “hidden gem” and expects segment EBITDA to more than double to over Rs 1,000 crore by FY31. It believes this business alone could eventually be worth more than Godrej Agrovet’s current market capitalisation.

Oil palm is already the company’s biggest profit contributor. In Q1FY27, the segment contributed just 22% of revenue but nearly 39% of operating profit, as improved extraction rates led to higher realisations.

Analysts expect more plantations and higher output from maturing trees to lift fruit volumes and drive growth in the oil palm segment. Godrej plans to nearly double the land under oil palm cultivation to 1.5 lakh hectares by 2031. The government’s National Mission on Edible Oils supports this growth by offering subsidies and assured prices to farmers, making it easier for Godrej to bring more farmers on board and expand cultivation. Around half of Godrej’s plantations are less than four years old, leaving room for fruit volumes to rise as these trees mature.

Godrej is also expanding beyond oil palm cultivation. It has opened an integrated oil palm complex in Telangana as part of a planned Rs 300 crore investment and is entering higher-value specialty fats used by food companies. This could help diversify revenue and improve margins. CEO Sunil Kataria said, “We expect this downstream business, when fully scaled up, should add close to 200 bps to our overall EBITDA profile.”

Overall Q1 revenue grew 9.2% YoY, but weaker margins dragged net profit down 16.2%. Delayed kharif sowing hurt demand for high-margin cotton herbicides in the crop care segment, while higher input costs pressured dairy and Godrej Foods segments.

The growth plan also carries execution risks. Oil palm fruit arrivals remained flat in Q1, and segment margins declined partly due to changes in the government-linked pricing formula. Future growth will depend on acreage expansion, higher output from maturing plantations and successful scaling of value-added products. 

3. Inox Wind:

The stock of this heavy electrical equipment company gained 4.8% on September 3 after securing a Rs 755 crore repeat order from Indian Oil Corporation for a 100 MW wind energy project. Under the agreement, the company will handle development from scratch, along with post-commissioning operations and maintenance (O&M) services. Group CEO Kailash Tarachandani highlighted that the win solidifies Inox Wind's standing as an integrated clean energy solutions provider with capabilities spanning the entire project lifecycle.

Despite an expanding order book, Q1FY27 performance remained subdued. First-quarter revenue edged up just 1.1% YoY to Rs 871.7 crore, while net profit plummeted 58.4% to Rs 44 crore, impacted by higher operating expenses and execution delays during the quarter. Looking ahead, Trendlyne’s Forecaster expects Q2 revenue to surge 43.2%, fueled by robust domestic demand and a solid order backlog.

On the expansion front, subsidiary Inox Green secured NCLT approval to acquire Wind World India's ~4.5 GW O&M portfolio, with transaction closure expected in Q2FY27. Reaffirming its full-year guidance, management expects ~75% revenue growth and 20–22% EBITDA margins in FY27. 

The company is strategically shifting toward equipment supply, which carries a lower working capital burden than contracts for end-to-end projects. This is reflected in its Q1 order book of 4.4 GW, with equipment supply accounting for 2.6 GW (59%) and turnkey projects for 1.8 GW (41%).

Motilal Oswal retained its ‘Buy’ rating on Inox Wind while trimming its target price to Rs 92. The brokerage noted that since Q1 delivered only about 8% of full-year revenue guidance, execution speed, third-party order inflows, and meeting target growth rates remain critical watchouts. Even so, analysts expect the company's performance to pick up significantly given its historically stronger second half.

4. Aster DM Quality Care: 

This hospital chain's stock surged 4.1% in the last week after its arm, Chemistry Intermediate Holdings, acquired a 14.2% stake in Bangladesh's STS Holdings for $44.1 million on August 28. This move aligns directly with the Aster-Quality Care merger agreement and signals a push into the broader South Asian healthcare market.

On September 2, promoter Union (Mauritius) Holdings bought 46.1 lakh shares worth Rs 350.3 crore from Centella Mauritius Holdings through a block deal at Rs 760 per share. 

These developments build on a strong Q1FY27 performance. Revenue rose 21.3% YoY to Rs 1,348 crore, beating Forecaster estimates. Higher patient volumes, better pricing, and a richer clinical trial & payor mix drove top-line growth.

Following its merger with Quality Care on July 1, Aster reported combined pro forma revenue of Rs 2,597 crore, nearly double its standalone Q1 revenue, thanks to an expanded network of over 38 hospitals with 10,150 beds. 

Management expects merger benefits to boost EBITDA by 10–15% in FY27, supported by sharing specialised doctors and clinical expertise across facilities, reducing the need for duplicated investments.

Looking ahead, CFO Sunil Kumar outlined the post-merger roadmap, saying, “We expect low-to-mid-teen revenue growth in FY27, while maintaining our target of 24-25% EBITDA margin (22% currently) in the next two to three years.” Higher patient volumes and increased average revenue per bed will fuel this growth. The company also plans to add 4,170 beds over the next three to four years, pushing total capacity near 15,000 beds. 

Following these moves, ICICI Direct retained a ‘Buy’ rating with a target price of Rs 895, implying a 13.9% upside. The brokerage expects bed additions, traction at mature hospitals, and merger benefits to drive revenue and profitability growth. Analysts project annual revenue and net profit to grow by 64% and 39%, respectively, through FY28.

5. Engineers India (EIL):

This engineering consultancy company surged 13% over the past week after 360 ONE Capital reiterated its positive stance and raised its target price to Rs 306, indicating 10% upside. The brokerage sees the shift towards higher-margin businesses, including opportunities in nuclear and data centres, as a key positive. It expects EIL to deliver more than 10% revenue growth in FY27, despite revenue coming in 15% below Forecaster estimates in Q1. 

The key change is in EIL’s business mix. Consultancy now accounts for 62% of turnover and earns significantly higher margins than project execution. This helped profit rise 142% YoY despite a decline in revenue in the past quarter. The company appears in a screener of stocks with annual profit growth higher than sector profit growth.

EIL’s order book stood at Rs 14,424 crore at the end of June, up 19% YoY, with consultancy accounting for 73% of the book. Order inflows reached Rs 2,750 crore by the August earnings call, and the management remains confident of achieving its Rs 8,000 crore target for FY27.

The company is also looking beyond its traditional hydrocarbon business for new consultancy opportunities. Nuclear is emerging as one such area, with EIL working on environmental studies for three private projects and one government project, while also pursuing consultancy assignments with Nuclear Power Corporation of India. Vivek Midha, Chief General Manager, Marketing and Business Development, said, “We have seen a lot of inquiries coming from the nuclear side.” Coal gasification and specialised infrastructure, including data centres, offer additional growth opportunities.

The main risks are weaker domestic or global capital spending, project execution delays and slower order activity in the Middle East. Management said new project activity in the region remains weak, although EIL secured around Rs 500 crore of business in Q1. Meanwhile, newer businesses such as nuclear and coal gasification are still at different stages of development and could take time to make a meaningful contribution to earnings.

Trendlyne's analysts identify stocks that are seeing interesting price movements, analyst calls, or new developments. These are not buy recommendations.